サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1404809

臨床試験施設管理機関の市場規模、シェア、動向分析レポート：臨床試験サービス/コンポーネント別、フェーズ別、治療分野別、地域別、セグメント別予測、2024年～2030年

Clinical Trial Site Management Organizations Market Size, Share & Trends Analysis Report By Clinical Trail Service/Component, By Phase, By Therapeutic Areas (Oncology, Cardiology, CNS), By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 275 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
臨床試験施設管理機関の市場規模、シェア、動向分析レポート：臨床試験サービス/コンポーネント別、フェーズ別、治療分野別、地域別、セグメント別予測、2024年～2030年
出版日: 2023年11月29日
発行: Grand View Research
ページ情報: 英文 275 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床試験施設管理機関市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の臨床試験施設管理機関の市場規模は2030年までに94億7,000万米ドルに達する見込みです。

同市場は2024年から2030年にかけてCAGR 6.17%で拡大する見込みです。治験施設管理組織（SMO）は、製薬・バイオ医薬品企業にとって不可欠な要素です。このような組織は、臨床研究に伴う負担を軽減するのに役立っています。SMOは、患者登録サービス、臨床試験地特有の試験活動への対応、試験スタッフの雇用、臨床試験サイトの運営監視など、いくつかのサービスを提供しています。統合された施設ネットワークと臨床試験サービスにおける世界の技術動向の改善、臨床サービスのアウトソーシングの動向の増加、慢性疾患や感染症の負担の大きさに起因する世界の臨床試験活動の拡大は、市場を牽引する要因の一部です。

テクノロジーは、現場の特定、選択、パフォーマンスなどの指標を改善することで、治験施設レベルでの効率性を向上させ、また、治験施設における募集、登録、選択、維持、コンプライアンス対策を分析することで、患者全体にわたる効率性を向上させています。さらに、技術的な改善により、生物統計学やデータ解析の分析が強化され、開発段階の早い段階で医薬品の実現可能性をより適切に評価できるようになりました。COVID-19パンデミックの結果、いくつかの組織は業務停止を余儀なくされ、また他の組織は完全な業務停止を余儀なくされました。しかし、SMOはマルチエセントリック試験を効果的に実施し、会社の経費と時間を節約しています。

パンデミックによる事業への悪影響を抑えるため、手作業のプロセスや事務処理はデジタル技術に取って代わられます。このため、SMOは、ウイルスの拡散を防ぐために物理的な接触がほぼ不可能な場合でも、あらゆる臨床研究の手順を合理化しながら、詳細な文書化を促進します。SMOの効率的なフォローアップスキルは、臨床研究を実施するためのバーチャル技術の採用とともに、患者募集に要する時間を大幅に短縮しています。世界のさまざまな地域で新種のウイルスが発見されているため、調査が最重要課題であることに変わりはないです。SMOは、データ収集、参加者や患者の安全確保、患者のリクルート、より正確な医師の連絡先情報、その他のタスクのために、医療やバイオテクノロジー企業から必要とされると思われます。したがって、このような要因が2021年中の市場全体の収益回復を支えています。

臨床試験施設管理機関市場レポートハイライト

  • プロジェクト管理セグメントは、2023年の売上高シェア25.0%で市場を独占しました。これは、臨床試験の設定、登録、期限内の報告、予算内での実施を確実にするために必要であるためです。
  • 第III相セグメントは2023年に54.16%と最大の売上シェアを占めました。この成長は、第III相試験がしばしば最大規模で数千人の参加者を含み、最も費用がかかるという事実に起因しています。
  • 治療分野別では、がん領域が予測期間中に市場で最も速いCAGR 6.66%を記録すると予測されています。これは、がんの世界の有病率の高さが医薬品需要を生み出し、市場シェアを拡大しているためです。
  • アジア太平洋地域は2023年に市場をリードし、予測期間中に最も速いCAGR 6.87%を記録すると予測されます。SMOが提供する費用対効果の高い戦略的ソリューションにより、臨床試験市場の変化、迅速なリクルート、膨大な患者プールが前提条件のいくつかであるように、タイムラインを短縮できるためです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 臨床試験施設管理機関（SMO）市場：変数、動向、および範囲

  • 市場セグメンテーションと範囲
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 普及と成長の見通しマッピング
  • COVID-19による市場への影響
  • 主要取引と戦略的提携の分析
  • 臨床試験施設管理機関（SMO）：市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 臨床試験施設管理機関（SMO）市場：臨床試験サービス/コンポーネントセグメント分析

  • 臨床試験施設管理機関（SMO）市場：定義と範囲
  • 臨床試験施設管理機関（SMO）：市場シェア分析、2023年および2030年
  • サイト管理
    • サイト管理市場、2018年～2030年
  • プロジェクト管理
    • プロジェクト管理市場、2018年～2030年
  • オンサイトモニタリング
    • オンサイトモニタリング市場、2018年～2030年
  • 規制
    • 規制市場、2018年～2030年
  • その他
    • その他の市場、2018年～2030年

第5章 臨床試験施設管理機関（SMO）市場：フェーズ分析

  • 臨床試験施設管理機関（SMO）市場：定義と範囲
  • 臨床試験施設管理機関（SMO）： 市場シェア分析、2023年および2030年
  • フェーズI
    • フェーズ I市場、2018年～2030年
  • フェーズ II
    • フェーズ II市場、2018年～2030年
  • フェーズⅢ
    • フェーズ III市場、2018年～2030年
  • フェーズ IV
    • フェーズ IV市場、2018年～2030年

第6章 治験施設管理組織（SMO）市場：治療領域分析

  • 臨床試験施設管理機関（SMO）市場：定義と範囲
  • 臨床試験施設管理機関（SMO）：市場シェア分析、2023年および2030年
  • 腫瘍学
    • 腫瘍学市場、2018年～2030年
  • 心臓病学
    • 循環器市場、2018年～2030年
  • 中枢神経系
    • CNS市場、2018年～2030年
  • 疼痛管理
    • 疼痛管理市場、2018年～2030年
  • 内分泌
    • 内分泌市場、2018年～2030年
  • その他
    • その他市場、2018年～2030年

第7章 臨床試験施設管理機関（SMO）市場：地域分析

  • 臨床試験施設管理機関（SMO）：市場シェア分析
  • 北米
    • 北米臨床試験施設管理機関
    • 米国
    • カナダ
  • 欧州
    • 欧州の臨床試験施設管理機関
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • アジア太平洋の臨床試験施設管理機関
    • インド
    • 日本
    • 中国
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ラテンアメリカの臨床試験施設管理機関
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカの臨床試験施設管理機関
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 企業プロファイル

  • 企業プロファイル
    • Clinedge
    • WCG
    • ClinChoice
    • Access Clinical Research
    • FOMAT Medical Research INC.
    • SGS
    • KV Clinical
    • SMO-Pharmina
    • Xylem Clinical Research
    • Aurum Clinical Research
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 4 Global Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 5 Global Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 6 Global Clinical Trial Site Management Organizations (SMOs) Market, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Clinical Trial Site Management Organizations (SMOs) Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 9 North America Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 10 North America Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 11 US Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 12 US Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 13 US Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 14 Canada Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 15 Canada Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 16 Canada Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 17 Europe Clinical Trial Site Management Organizations (SMOs) Market, by Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 19 Europe Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 20 Europe Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 21 Germany Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 22 Germany Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 23 Germany Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 24 UK Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 25 UK Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 26 UK Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 27 France Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 28 France Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 29 France Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 30 Italy Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 31 Italy Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 32 Italy Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 33 Spain Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 34 Spain Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 35 Spain Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 36 Denmark Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 37 Denmark Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 38 Denmark Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 39 Sweden Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 40 Sweden Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 41 Sweden Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 42 Norway Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 43 Norway Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 44 Norway Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, by Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 49 China Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 50 China Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 51 China Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 52 Japan Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 53 Japan Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 54 Japan Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 55 India Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 56 India Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 57 India Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 58 South Korea Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 59 South Korea Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 60 South Korea Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 61 Australia Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 62 Australia Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 63 Australia Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 64 Thailand Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 65 Thailand Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 66 Thailand Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 67 Latin America Clinical Trial Site Management Organizations (SMOs) Market, by Country, 2018 - 2030 (USD Million)
  • Table 68 Latin America Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 69 Latin America Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 70 Latin America Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 71 Brazil Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 72 Brazil Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 73 Brazil Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 74 Mexico Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 75 Mexico Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 76 Mexico Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 77 Argentina Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 78 Argentina Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 79 Argentina Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Clinical Trial Site Management Organizations (SMOs) Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 84 South Africa Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 85 South Africa Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 86 South Africa Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 90 UAE Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 91 UAE Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 92 UAE Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Clinical Trial Site Management Organizations (SMOs) Market, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global Clinical Trial Site Management Organizations (SMOs) Market, for Phase I, 2018 - 2030 (USD Million)
  • Fig. 13 Global Clinical Trial Site Management Organizations (SMOs) Market, for Phase II, 2018 - 2030 (USD Million)
  • Fig. 14 Global Clinical Trial Site Management Organizations (SMOs) Market, for Phase III, 2018 - 2030 (USD Million)
  • Fig. 15 Global Clinical Trial Site Management Organizations (SMOs) Market, for Phase IV, 2018 - 2030 (USD Million)
  • Fig. 16 Global Clinical Trial Site Management Organizations (SMOs) Market, for Site Management, 2018 - 2030 (USD Million)
  • Fig. 17 Global Clinical Trial Site Management Organizations (SMOs) Market, for Project Management, 2018 - 2030 (USD Million)
  • Fig. 18 Global Clinical Trial Site Management Organizations (SMOs) Market, for Regulatory , 2018 - 2030 (USD Million)
  • Fig. 19 Global Clinical Trial Site Management Organizations (SMOs) Market, for Onsite Monitoring, 2018 - 2030 (USD Million)
  • Fig. 20 Global Clinical Trial Site Management Organizations (SMOs) Market, for Others , 2018 - 2030 (USD Million)
  • Fig. 21 Global Clinical Trial Site Management Organizations (SMOs) Market, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 22 Global Clinical Trial Site Management Organizations (SMOs) Market, for Cardiology , 2018 - 2030 (USD Million)
  • Fig. 23 Global Clinical Trial Site Management Organizations (SMOs) Market, for CNS, 2018 - 2030 (USD Million)
  • Fig. 24 Global Clinical Trial Site Management Organizations (SMOs) Market, for Pain Management, 2018 - 2030 (USD Million)
  • Fig. 25 Global Clinical Trial Site Management Organizations (SMOs) Market, for Enodcrine, 2018 - 2030 (USD Million)
  • Fig. 26 Global Clinical Trial Site Management Organizations (SMOs) Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 27 Regional Outlook, 2021 & 2030
  • Fig. 28 North America Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 30 Canada Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 31 Europe Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 32 Germany Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 33 UK Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 34 France Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 35 Italy Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 36 Spain Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 37 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 38 Japan Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 39 China Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 40 India Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 41 Australia Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 42 South Korea Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 43 Latin America Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 44 Brazil Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 45 Mexico Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 46 Argentina Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 47 Colombia Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 48 Middle East and Africa Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 49 South Africa Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 51 UAE Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68039-921-9

Clinical Trials Site Management Organizations Market Growth & Trends:

The global clinical trials site management organizations market size is expected to reach USD 9.47 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.17% from 2024 to 2030. Site management organizations (SMOs) are essential elements of pharmaceutical and biopharmaceutical companies. Such organizations help to limit the burden associated with clinical research. SMOs offer several services including patient enrollment services, addressing clinical trial location-specific study activities, hiring study staff, and monitoring clinical studies site operations. Improved technological use in integrated site networks and clinical trial services, increasing trend of outsourced clinical services, and growing clinical trial activities globally owing to the high burden of chronic and infectious diseases, are few of the factors driving the market.

Technology has improved efficiencies at the site level by improving metrics such as on-site identification, selection, and performance, as well as throughout the patient spectrum by analyzing recruitment, enrollment, selection, retention, and compliance measures at sites. Furthermore, technical improvements have resulted in enhanced biostatistics and data analytics analysis to better evaluate a drug's feasibility early in the development phase. As a result of the COVID-19 pandemic, several organizations were forced to halt operations while others were forced to completely shut down. However, the SMOs execute multi-eccentric trials effectively to save the firm money and time.

Manual processes and paperwork are replaced by digital technologies to limit the negative impact of the pandemic on the business. Due to this, Site Management Organization facilitates detailed documentation while also streamlining the procedure in any clinical research, even when physical contact is nearly impossible to prevent viral spread. SMO's efficient follow-up skills along with the adoption of virtual technologies to conduct clinical research have significantly decreased the time required to recruit patients. As new virus strains are being discovered in different areas of the world, research would remain a top focus. SMOs would be required by health and biotech companies for data collection, participant or patient safety, patient recruitment, more accurate doctor contact information, and other tasks. Hence, such factors are supporting the rebound of revenues across the market during 2021.

Clinical Trials Site Management Organizations Market Report Highlights:

  • The project management segment dominated the market with a revenue share of 25.0% in 2023, due to the fact that it is required to ensure that clinical trials are set up, enrolled, reported on time, and conducted within the budget
  • The phase III segment accounted for the largest revenue share of 54.16% in 2023. This growth is attributed to the fact that phase III trials are often the largest and involve thousands of participants and are the most expensive ones
  • Based on therapeutic area, the oncology segment is anticipated to witness the fastest CAGR of 6.66% in the market during the forecast period, due to the high global prevalence of cancer, which is generating demand for drugs and thus increasing its market share
  • Asia Pacific led the market in 2023 and is projected to witness the fastest CAGR of 6.87% during the forecast years, as cost-effective strategic solutions provided by SMOs could reduce timelines, as in changing market for clinical trials, fast recruitment, and a huge pool of patients are some of the prerequisites

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Estimates and Forecast Timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis (model 1)
    • 1.6.2. Volume Price Analysis (model 2)
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. List of Abbreviations
  • 1.10 Objectives
    • 1.10.1. Objective - 1
    • 1.10.2. Objective - 2
    • 1.10.3. Objective - 3
    • 1.10.4. Objective - 4

Chapter 2 Executive Summary

  • 2.1. Market Outlook

Chapter 3 Clinical Trial Site Management Organizations (SMOs) Market: Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1 Growth in the number of clinical Studies
      • 3.2.1.2. Rising investment in R&D by the pharmaceutical companies.
      • 3.2.1.3. Increasing rate of clinical trials outsourcing by pharmaceutical and biopharmaceutical companies.
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of clinical studies
      • 3.2.2.2. Presence of significant CROs offering site management services possesses the threat to steal its market share
  • 3.3. Penetration & Growth Prospect Mapping
  • 3.4. COVID-19 Impact on the Market
  • 3.5. Major Deals and Strategic Alliances Analysis
  • 3.6. Clinical Trial Site Management Organizations (SMO)s: Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
    • 3.6.2. PESTEL Analysis

Chapter 4 Clinical Trial Site Management Organizations (SMOs) Market: Clinical Trial Services/ Components Segment Analysis

  • 4.1 Clinical Trial Site Management Organizations (SMOs) Market: Definition & Scope
  • 4.2 Clinical Trial Site Management Organizations (SMO): Market Share Analysis, 2023 & 2030
  • 4.3 Site Management
    • 4.3.1 Site Management Market, 2018 - 2030 (USD Million)
  • 4.4 Project Management
    • 4.4.1 Project Management market, 2018 - 2030 (USD Million)
  • 4.5 Onsite Monitoring
    • 4.5.1 Onsite Monitoring market, 2018 - 2030 (USD Million)
  • 4.6 Regulatory
    • 4.6.1 Regulatory Market, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1 Others market, 2018 - 2030 (USD Million)

Chapter 5 Clinical Trial Site Management Organizations (SMOs) Market: Phase Analysis

  • 5.1 Clinical Trial Site Management Organizations (SMOs) Market: Definition & Scope
  • 5.2 Clinical Trial Site Management Organizations (SMO) : Market Share Analysis, 2023 & 2030
  • 5.3 Phase I
    • 5.3.1 Phase I Market, 2018 - 2030 (USD Million)
  • 5.4. Phase II
    • 5.4.1 Phase II Market, 2018 - 2030 (USD Million)
  • 5.5 Phase III
    • 5.5.1. Phase III Market, 2018 - 2030 (USD Million)
  • 5.6 Phase IV
    • 5.6.1. Phase IV Market, 2018 - 2030 (USD Million)

Chapter 6 Clinical Trial Site Management Organizations (SMOs) Market: Therapeutic Area Analysis

  • 6.1 Clinical Trial Site Management Organizations (SMOs) Market: Definition & Scope
  • 6.2 Clinical Trial Site Management Organizations (SMO): Market Share Analysis, 2023 & 2030
  • 6.3 Oncology
    • 6.3.1 Oncology Market, 2018 - 2030 (USD Million)
  • 6.4. Cardiology
    • 6.4.1 Cardiology Market, 2018 - 2030 (USD Million)
  • 6.5 CNS
    • 6.5.1. CNS Market, 2018 - 2030 (USD Million)
  • 6.6 Pain Management
    • 6.6.1. Pain Management Market, 2018 - 2030 (USD Million)
  • 6.7 Endocrine
    • 6.7.1. Endocrine Market, 2018 - 2030 (USD Million)
  • 6.8 Others
    • 6.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7 Clinical Trial Site Management Organizations (SMOs) Market: Regional Analysis

  • 7.1 Clinical Trial Site Management Organizations (SMO): Market Share Analysis
  • 7.2 North America
    • 7.2.1 North America Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.3.2 UK
      • 7.3.2.1 UK Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Germany Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 France Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Italy Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 Spain Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030(USD Million)
    • 7.3.7 Denmark
      • 7.3.7.1 Denmark Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.3.8 Sweden
      • 7.3.8.1 Sweden Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.3.9 Norway
      • 7.3.9.1 Norway Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030(USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.4.2 India
      • 7.4.2.1 India Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.4.3 Japan
      • 7.4.3.1 Japan Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.4.4 China
      • 7.4.4.1 China Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.4.5 Australia
      • 7.4.5.1 Australia Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.4.6 South Korea
      • 7.4.6.1 South Korea Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.4.7 Thailand
      • 7.4.7.1 Thailand Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.5.4 Argentina
      • 7.5.4.1 Argentina Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • 7.6 MEA
    • 7.6.1 MEA Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.6.4 UAE
      • 7.6.4.1 UAE Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.6.5 Kuwait
      • 7.6.5.1 Kuwait Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Company Profiles
    • 8.1.1 Clinedge
      • 8.1.1.1 Company Overview
      • 8.1.1.2 Financial Performance
      • 8.1.1.3 Service Benchmarking
      • 8.1.1.4 Strategic Initiative
    • 8.1.2 WCG
      • 8.1.2.1 Company Overview
      • 8.1.2.2 Financial Performance
      • 8.1.2.3 Service Benchmarking
      • 8.1.2.4 Strategic Initiative
    • 8.1.3 ClinChoice
      • 8.1.3.1 Company Overview
      • 8.1.3.2 Financial Performance
      • 8.1.3.3 Service Benchmarking
      • 8.1.3.4 Strategic Initiatives
    • 8.1.4 Access Clinical Research
      • 8.1.4.1 Company Overview
      • 8.1.4.2 Financial Performance
      • 8.1.4.3 Service Benchmarking
      • 8.1.4.4 Strategic Initiatives
    • 8.1.5 FOMAT Medical Research INC.
      • 8.1.5.1 Company Overview
      • 8.1.5.2 Financial Performance
      • 8.1.5.3 Service Benchmarking
      • 8.1.5.4 Strategic Initiatives
    • 8.1.6 SGS
      • 8.1.6.1 Company Overview
      • 8.1.6.2 Financial Performance
      • 8.1.6.3 Service Benchmarking
      • 8.1.6.4 Strategic Initiatives
    • 8.1.7 KV Clinical
      • 8.1.7.1 Company Overview
      • 8.1.7.2 Financial Performance
      • 8.1.7.3 Service Benchmarking
      • 8.1.7.4 Strategic Initiatives
    • 8.1.8 SMO-Pharmina
      • 8.1.8.1 Company Overview
      • 8.1.8.2 Financial Performance
      • 8.1.8.3 Service Benchmarking
      • 8.1.8.4 Strategic Initiatives
    • 8.1.9 Xylem Clinical Research
      • 8.1.9.1 Company Overview
      • 8.1.9.2 Financial Performance
      • 8.1.9.3 Service Benchmarking
      • 8.1.9.4 Strategic Initiatives
    • 8.1.10 Aurum Clinical Research
      • 8.1.10.1 Company Overview
      • 8.1.10.2 Financial Performance
      • 8.1.10.3 Service Benchmarking
      • 8.1.10.4 Strategic Initiatives